Praxis Precision Medicines, Inc. Common Stock (PRAX) Financials
Key financial figures for Praxis Precision Medicines, Inc. Common Stock (Q2 2026).
Praxis Precision Medicine Inc reported revenue of $0.00 for Q2 FY2026. The company posted a net loss of $83.7 million, or -$2.87 per share. Free cash flow for the period was -$77.9 million. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Praxis Precision Medicine Inc are on the SentiSense financials page.
- Revenue
- $0
- Net Income
- -$84M
- EPS
- $-2.87
- Total Assets
- $1.4B
- Operating Cash Flow
- -$78M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $0 | -$84M | -$2.87 | -$78M | |
| Q1 FY2026 | $0 | -$93M | -$3.20 | -$86M | |
| Q4 FY2025 | $0 | -$89M | -$3.50 | -$77M | |
| Q3 FY2025 | $0 | -$74M | -$3.36 | -$65M | |
| Q2 FY2025 | $0 | -$71M | -$3.31 | -$55M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $0 | -$303M | -$13.48 | -$249M | |
| FY2024 | $9M | -$183M | -$10.21 | -2340.29% | -$132M |
| FY2023 | $2M | -$123M | -$18.69 | -5164.41% | -$111M |
Frequently asked questions
What was Praxis Precision Medicine Inc's revenue last quarter?
Praxis Precision Medicine Inc reported revenue of $0.00 for Q2 FY2026.
Is Praxis Precision Medicine Inc profitable?
Not in its most recent reported period. Praxis Precision Medicine Inc reported a net loss of $83.7 million for Q2 FY2026.
How much free cash flow did Praxis Precision Medicine Inc generate?
Praxis Precision Medicine Inc generated free cash flow of -$77.9 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Praxis Precision Medicines, Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.